A LOOK AT THE ORGANIZATIONAL AND MODERN PATHOGENETIC FOUNDATIONS OF OSTEOARTHRITIS DEVELOPMENT
Keywords:
osteoarthritis, pathological physiology, organization of careAbstract
Objective: literature review on the problems of organization of medical care for patients with osteoarthritis (OA), based on the definition of the main pathogenetic mechanisms of its occurrence.
References
Гаркави А.В. Остеоартроз. Медицинская газета. Профессиональное врачебное издание. 2012; 85:8-9
Коваленко В.Н., Борткевич О.П. Остеоартроз. Практическое руководство. К.: Морион; 2003
Матвеев Р.П., Брагина С.В. Остеоартроз коленного сустава: проблемы и социальная значимость // Экология человека. Медицинская экология. 2012.09, стр.53-62
Олюнин Ю.А. Диагностика и лечение остеоартроза в реальной клинической практике. ФГБУ НИИ ревматологии РАМН. М.: // Consilium Medicum. Неврология и ревматология. 2012;2:58-61.
Стасевич Н.Ю., Смыслов И.Н., Немсцверидзе Э.Я. Организационные основы совершенствования гериатрической помощи в медицинских учреждениях разной формы собственности / Социальные аспекты здоровья населения [сетевое издание] 2015; 42 (2). URL:http://vestnik.mednet.ru/content/view/671/30/lang,ru
Четина Е.В. Признаки дифференциации хондроцитов при формировании ранних повреждений хряща у пожилых людей // Научно-практическая ревматология. 2011. № 1. С. 33–39
Nüesch E., Dieppe P., Reichenbach S., Williams S., Iff S., Jüni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011; 342:d1165.
Hawker G.A., Croxford R., Bierman A.S., et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLoS One 2014; 9:e91286.
National Clinical Guideline Centre (UK). Osteoarthritis: Care and Management in Adults. London: National Institute for Health and Care Excellence (UK), 2014. https://www.ncbi.nlm.nih.gov/books/NBK248069/ (accessed Dec 8, 2020).
Kolasinski S.L., Neogi T., Hochberg M.C., et al. American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2020;72:149-62.
Bannuru R.R., Osani M.C., Vaysbrot E.E., et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019;27:1578-89.
Larochelle M.R., Zhang F., Ross-Degnan D., Wharam J.F. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010. Pharmacoepidemiol Drug Saf 2015; 24:885-92.
Krebs E.E., Gravely A., Nugent S., et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE randomized clinical trial. // JAMA 2018; 319:872-82.
Busse J.W., Wang L., Kamaleldin M., et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. // JAMA.2018;.320:2448-60.
Busse J.W., Craigie S., Juurlink D.N., et al. Guideline for opioid therapy and chronic noncancer pain. // CMA J 2017; 189: E659-66.
Avouac J., Gossec L.,Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007; 15:957-65.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396:1204-22.
Jeffery M.M., Hooten W.M., Henk H.J., et al. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study. BMJ 2018; 362:k2833.
Power J.D., Perruccio A.V., Gandhi R., et al. Factors associated with opioid use in presurgical knee, hip, and spine osteoarthritis patients. Arthritis Care Res (Hoboken) 2019; 71:1178-85.
Desai R.J., Jin Y., Franklin P.D., et al. Association of geography and access to health care providers with long-term prescription opioid use in Medicare patients with severe osteoarthritis: a cohort study. // Arthritis Rheumatol.2019; 71:712-21.
Cao Z., Zhou J., Long Z., et al. Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs. Aging (Albany NY).2020; 13:1051-70.
Smith S.R., Deshpande B.R., Collins J.E., Katz J.N., Losina E. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. // Osteoarthritis Cartilage 2016; 24:962-72.
Zeng C., Wei J., Persson M.S.M., et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med 2018; 52:642-50.
da Costa B.R., Saadat P., Basciani R.M., et al. Visual Analogue Scale has higher assay sensitivity than WOMAC pain in detecting between-group differences in treatment effects: a meta-epidemiological study. Osteoarthritis Cartilage 2021; 29:304-12.
Dias S., Welton N.J., Sutton A.J., Ades A.E. NICE DSU Technical Support Document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. National Institute for Health and Care Excellence (NICE), London. 2014. https://www.ncbi.nlm.nih.gov/books/NBK310366/.
Feng X., Tian M., Zhang W., Mei H. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis. PLoS One 2018; 13:e0190798.
Persson M.S.M., Stocks J., Walsh D.A., Doherty M., Zhang W. The relative efficacy of topical non-steroidal anti-inflammatory drugs and capsaicin in osteoarthritis: a network meta-analysis of randomised controlled trials. Osteoarthritis Cartilage 2018; 26:1575-82.
